PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Guwahati, India; Department of Biomedical Engineering, Indian Institute of Technology (IIT), Ropar 140001, India.\', \'Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Ahmedabad, India.\', \'Department of Pharmacology, Jamia Hamdard, New Delhi, India.\', \'Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research, Guwahati, India.\', \'Biotechnology Institute, Ankara University, Ankara, Turkey.\', \'Department of Pharmaceutics, College of Pharmacy, University of Hail, Hail, Saudi Arabia.\', \'Department of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia.\', \'Department of Pharmacology & Toxicology, College of Pharmacy, University of Hail, Hail, Saudi Arabia. Electronic address: si.anwar@uoh.edu.sa.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1876-0341(22)00002-810.1016/j.jiph.2021.12.014
?:doi
?:hasPublicationType
?:journal
  • Journal of infection and public health
is ?:pmid of
?:pmid
?:pmid
  • 35042059
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.648
?:rankingScore_hIndex
  • 23
?:title
  • The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all